<DOC>
	<DOCNO>NCT01959815</DOCNO>
	<brief_summary>Patients scleroderma develop heart failure due high blood pressure lung ( condition call pulmonary arterial hypertension ) . It important find pulmonary arterial hypertension early , treat heart failure develop . However , test use find early form disease scleroderma patient good enough . This study examine whether test perform exercise improve ability find early pulmonary arterial hypertension . The study also try identify gene responsible development pulmonary arterial hypertension .</brief_summary>
	<brief_title>Novel Screening Strategies Scleroderma PAH</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<criteria>30 year old ; diagnosis limit diffuse scleroderma ( American College Rheumatology criterion ) `` high risk '' group , one follow feature : rest transthoracic echocardiogram showing elevate rightsided pressure within previous 3 month [ tricuspid regurgitation ( TR ) jet &gt; 2.8 m/s evidence right ventricular dysfunction ] pulmonary function test ( PFT ) show abnormal diffuse capacity carbon monoxide ( DLCO ) due significant interstitial lung disease ( DLCO &lt; 60 % predict FVC : DLCO ratio &gt; 1.4 ) Pregnancy prior diagnosis pulmonary hypertension treatment endothelin receptor antagonist , phosphodiesterase5 inhibitor , prostacyclin analogue previous diagnosis obstructive lung disease pulmonary thromboembolic disease current smoker significant valvular disease rest echocardiogram showing leave ventricular ejection fraction &lt; 50 % within previous 3 month rest echocardiogram showing significant ( great Grade I ) diastolic dysfunction pulmonary embolus ( past present ) .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>